Jacobs Levy Equity Management
VRTX icon

Jacobs Levy Equity Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$22.7M Sell
50,956
-15,278
-23% -$6.8M 0.09% 198
2025
Q1
$32.1M Buy
+66,234
New +$32.1M 0.13% 172
2024
Q1
Sell
-100,868
Closed -$41M 1063
2023
Q4
$41M Sell
100,868
-468,612
-82% -$191M 0.21% 115
2023
Q3
$198M Buy
569,480
+19,010
+3% +$6.61M 1.17% 12
2023
Q2
$194M Sell
550,470
-71,944
-12% -$25.3M 1.12% 11
2023
Q1
$196M Sell
622,414
-13,578
-2% -$4.28M 1.2% 11
2022
Q4
$184M Buy
635,992
+434,318
+215% +$125M 1.24% 9
2022
Q3
$58.4M Buy
201,674
+62,213
+45% +$18M 0.46% 49
2022
Q2
$39.3M Buy
139,461
+86,428
+163% +$24.4M 0.3% 86
2022
Q1
$13.8M Buy
53,033
+17,769
+50% +$4.64M 0.09% 240
2021
Q4
$7.74M Sell
35,264
-421,858
-92% -$92.6M 0.05% 348
2021
Q3
$82.9M Sell
457,122
-172,787
-27% -$31.3M 0.56% 40
2021
Q2
$127M Buy
629,909
+612,225
+3,462% +$123M 0.86% 12
2021
Q1
$3.8M Sell
17,684
-114,685
-87% -$24.6M 0.03% 474
2020
Q4
$31.3M Buy
132,369
+96,451
+269% +$22.8M 0.27% 95
2020
Q3
$9.77M Sell
35,918
-18,465
-34% -$5.02M 0.1% 215
2020
Q2
$15.8M Buy
+54,383
New +$15.8M 0.17% 147
2019
Q2
Sell
-92,342
Closed -$17M 1036
2019
Q1
$17M Sell
92,342
-230,348
-71% -$42.4M 0.25% 107
2018
Q4
$53.5M Buy
322,690
+67,840
+27% +$11.2M 0.94% 10
2018
Q3
$49.1M Buy
254,850
+30,060
+13% +$5.79M 0.7% 12
2018
Q2
$38.2M Buy
224,790
+22,320
+11% +$3.79M 0.6% 17
2018
Q1
$33M Buy
202,470
+5,930
+3% +$966K 0.55% 24
2017
Q4
$29.5M Buy
196,540
+11,590
+6% +$1.74M 0.52% 29
2017
Q3
$28.1M Buy
184,950
+9,096
+5% +$1.38M 0.55% 33
2017
Q2
$22.7M Sell
175,854
-39,756
-18% -$5.12M 0.48% 50
2017
Q1
$23.6M Sell
215,610
-24,140
-10% -$2.64M 0.48% 57
2016
Q4
$17.7M Buy
239,750
+230,960
+2,628% +$17M 0.34% 86
2016
Q3
$767K Buy
+8,790
New +$767K 0.01% 626
2014
Q2
Sell
-68,920
Closed -$4.87M 940
2014
Q1
$4.87M Buy
+68,920
New +$4.87M 0.08% 262